As. Allal et al., IMPACT OF CLINICAL AND THERAPEUTIC FACTORS ON MAJOR LATE COMPLICATIONS AFTER RADIOTHERAPY WITH OR WITHOUT CONCOMITANT CHEMOTHERAPY FOR ANALCARCINOMA, International journal of radiation oncology, biology, physics, 39(5), 1997, pp. 1099-1105
Citations number
22
Categorie Soggetti
Oncology,"Radiology,Nuclear Medicine & Medical Imaging
Purpose: To investigate factors potentially influencing major late mor
bidity after sphincter-conserving treatment for anal carcinoma. Method
s and Materials: Grade 3-4 complications were retrospectively analysed
in 144 evaluable patients (pts), 55 pts after split-course radiothera
py (RT), and 89 after concomitant chemo-RT. First sequence RT delivere
d a median dose of 39.6 Gy using megavoltage photon beams, Boost treat
ment used either Ir-192 implantation or external beam RT (median dose
20 Gy), Chemotherapy started on day 1 and in 83% of pts consisted of M
itomycin-C (10 mg/m(2)) and a 5-day infusion of 5-fluorourcil (600-800
mg/m(2)/day), Uni-and multivariate analyses tested the association of
following factors with complication rate: age, gender, stage, anatomi
c tumor extent, type of biopsy, external RT technique (dose, fraction
size, field arrangement), boost type (brachytherapy vs, external), bra
chytherapy dose and dose rate, overall treatment time, and addition of
chemotherapy. Results: Five-year actuarial complication rate was 16%,
Two variables were significantly associated with complication rate: a
natomic tumor extent (canal or margin vs. both +/- rectum; 10 vs, 31%
complications, p = 0.0004) and first sequence prescribed dose (<39.6 G
y vs. greater than or equal to 39.6 Gy; 7 vs, 23% complications, p = 0
.012), confirmed as independent factors by Cox analysis, Grade 4 anal
morbidity correlated significantly with prior local excision, All six
bone complications were observed in pts treated by chemo-RT using larg
e pelvic fields, five occurring in pts older than 66. Conclusion: Pts
with tumors involving more than one anatomic subsite or treated with t
he higher first sequence RT dose are at greater risk of major complica
tions. Prior tumor excision and combined modality therapy in older pts
appear to favor major anal and bone complications, respectively. (C)
1997 Elsevier Science Inc.